Clinical Characteristics and Evaluation of Prognostic Factors in Patients with Myelodysplastic Syndromes Treated in 2008-2012
DOI:
https://doi.org/10.12775/mbs-2013-0006Keywords
myelodysplastic syndrome, MDS register, WHO classification, prognostic factorsAbstract
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic disorders characterized by one, two or three systems peripheral cytopenia and a tendency to transform to acute myeloid leukemia. Myelodysplastic syndromes are the most common hematological malignancies in adults. The present study is one of the few retrospective analyses carried out in Poland for patients with myelodysplastic syndromes. Our study involved 178 patients hospitalized from January 2008 to the end of April 2012 in the Department of Clinical Haematology and Haematological Malignancies Diseases, University Hospital No. 2 in Bydgoszcz. The data were collected retrospectively on the basis of detailed surveys taking into account a number of demographic, clinical and prognostic factors. The analysis showed a significantly positive correlation between MDS and male sex, older age as well as the place of residence in the city. The classification of clinical data, laboratory parameters and prognostic factors showed that the majority of MDS patients represented a low-risk group; about 6% of patients experienced a transformation in acute myeloid leukemia, and the leading causes of death were infectious complications and septic shock. The data collected indicate the need for cytogenetic testing in all patients with MDS to determine the prognosis and indications for treatment.References
Dmoszyńska A.: Leczenie rozrostowych chorób hematologicznych. Wydawnictwo: Medycyna Praktyczna, Kraków 2011: 157-167
Dwilewicz-Trojaczek J. i wsp.: Diagnostyka, klasyfikacja i leczenie zespołów mielodysplastycznych - zalecenia ekspertów polskich. Acta Haematologica Polonica 2010, 41, Nr 1, str. 101-114.
Valent P., Horny H., Bennett J.M. et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statement and report from a working conference. Leuk Res 2007; 31: 727-736.[ http://dx.doi.org/10.1016/j.leukres.2006.11.009]
Brunning R.D., Bennett J.M., Flandrin G. et al. Myelodysplastic syndromes. In: Jaffe E.S., Harris N.L., Stein H. editors. World Health Organization Classification of Tumours. Pathology and genetics. Tumours of Haematopoietic and Lymphoid Tissues, vol. 1. Lyon: IARC Press 2001: 62-73.
Brunning R.D., Orazi A., Germing U. et al. Myelodysplastic syndromes/neoplasms. In: Swerdlow S.H., Campo E., Harris N.L., editors. World Health Organization Classification of Tumours. Pathology and genetics. Tumours of Haematopoietic and Lymphoid Tissues, vol. 2. Lyon: IARC Press 2008: 88-107.
Greenberg P., Cox C., Le Beau M.M. et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89 (6): 2079-2088.
Malcovati L., Germing U., Kuendgen A. et al. Timedependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007; 25 (23): 3503-3510.
Kantarijan H. et al. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 2008; 113: 1351-61. [http://dx.doi.org/10.1002/cncr.23697]
Germing U., Aul C., Niemeyer C.M. i wsp. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann. Hematol. 2008; 87: 691-699.[ http://dx.doi.org/10.1007/s00277-008-0499-3]
Atallah E., Garcia-Manero G. Treatment strategies In myelodysplastic syndromes. Cancer Invest. 2008; 26: 208-216. [http://dx.doi.org/10.1080/07357900701788122]
Nimer S.D. Myelodysplastic syndromes. Blood 2008; 111: 4841-4851. [http://dx.doi.org/10.1182/blood-2007-08-078139]
Dwilewicz-Trojaczek J., Mądry K., Hołowiecka B.S. i wsp. Polish Myelodysplastic Syndromes Registry - Report of 15 Months of Activity. Blood (ASH Annual Meeting Abstracts) 2009 114: Abstract 4848.
Porter J.B. Practical management of iron overload. Br j Haematol 2001; 115:239-25.
Downloads
Published
How to Cite
Issue
Section
Stats
Number of views and downloads: 167
Number of citations: 0